Advertisement

Metastases in the Bone Marrow

  • B. Frisch
  • R. Bartl
Part of the Current Histopathology book series (CUHI, volume 15)

Abstract

The introduction of advanced technology for obtaining biopsies under radiological guidance, improvements in biopsy needles, the development of specific monoclonal antibodies and tumour markers, and the progress in histological techniques have led to a widespread upsurge of interest in examination of the bone marrow for detection of metastases1-11. Moreover, evidence has now accumulated that any primary tumour has the ability to spread as soon as it is established and has access to lymphatic or blood vessels. Metastatic potential is also related to the cellular heterogeneity of the primary tumour12.

Keywords

Breast Cancer Bone Marrow Bone Marrow Biopsy Prussian Blue Skeletal Metastasis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Weiss, L. and Gilbert, H.A. (eds) (1981). Bone Metastasis, Boston: G. K. Hall Medical PublishersGoogle Scholar
  2. 2.
    Frisch, B., Bartl R., Burkhardt, R. (1982). Bone marrow biopsy in clinical medicine: an overview. Haematologia, 3, 245Google Scholar
  3. 3.
    Frisch, B., Bartl, R., Mahl, G. and Burkhardt, R. (1984). Scope and value of bone marrow biopsies in metastatic cancer. Invasion Metastasis, 4, (Suppl. 1), 12PubMedGoogle Scholar
  4. 4.
    Frisch, B., Lewis, S. M., Burkhardt, R. and Bartl, R. (1985). Biopsy Pathology of Bone and Bone Marrow. London: Chapman and HallGoogle Scholar
  5. 5.
    Scanlon, E. F. (1985). The process of metastasis. Cancer, 55, 1166CrossRefGoogle Scholar
  6. 6.
    Poste, G. (1986). Pathogenesis of metastatic disease: implications for current therapy and for the development of new therapeutic strategies. Cancer Treat. Reports, 70, 183Google Scholar
  7. 7.
    Schlimok, G., Funke, I., Holzmann, B., Gottlinger, G., Schmidt, G., Hauser, H., Swierkot, S., Warnecke, H. H., Scheider, B., Koprowski, H. et al. (1987). Micrometastatic cancer cells in bone marrow: in vitro detection with anti-cytokeratin and in vivo labeling with anti-17–1A monoclonal antibodies. Proc. Natl. Acad. Sci. USA, 84, 8672PubMedCrossRefGoogle Scholar
  8. 8.
    Pignon, T., Ralantoarimihanta, M., Vicens, R. and Coulanges, P. (1987). Bone marrow examination in cancerology. Apropos of 92 marrow biopsies performed at the Antananarivo Hemato-cancerology Service. Arch. Inst. Pasteur-Madagascar, 53, 157PubMedGoogle Scholar
  9. 9.
    Wang, J. M., Shih, L Y., Lai, G. M. and Ng, K. T. (1987). Bone marrow metastases from solid tumours — clinical analysis of 96 cases. Chang. Keng. I. Hseuh, 10, 283Google Scholar
  10. 10.
    Favrot, M. C. and Herve, P. (1987). Detection of minimal malignant cell infiltration in the bone marrow of patients with solid tumours, non-Hodgkin lymphomas and leukaemias. Bone Marrow Transplant, 2, 117PubMedGoogle Scholar
  11. 11.
    Im, T., Yamane, T., Sagawa, H., Hiyoshi, M., Kishida, T., Sasaki, A., Yokomatsu, Y., Kojima, K., Sannomiya, Y., Yoshikawa, T. et al. (1987). Clinicopathological study of cancer metastasis to bone marrow by bone marrow biopsy. Rinsho. Byori, 35, 1292PubMedGoogle Scholar
  12. 12.
    Schnippen, L. E. (1986). Clinical implications of tumour-cell heterogeneity. N. Engl. J. Med., 314, 1423CrossRefGoogle Scholar
  13. 13.
    Al-Mondhiry, H. and McGarvey, V. (1987). Tumour interaction with vascular endothelium. Haemostasis, 17, 245PubMedGoogle Scholar
  14. 14.
    Castello, A., Coci, A., Magnini, U. and Ascari, E. (1986). Histopathology of bone marrow metastases. Considerations on 104 cases. Haematologia, 71, 369Google Scholar
  15. 15.
    Willis, R. A. (1973). The Spread of Tumours in the Human Body, London: ButterworthsGoogle Scholar
  16. 16.
    Henson, D. E. (1988). The histological grading of neoplasms. Arch. Pathol., Lab. Med., 112, 1091Google Scholar
  17. 17.
    Dvorak, H. F. (1986). Tumours: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med., 315, 1650PubMedCrossRefGoogle Scholar
  18. 18.
    Sporn, M. B. and Roberts, A. B. (1986). Peptide growth factors and inflammation, tissue repair, and cancer. J. Clin. Invest, 78, 329PubMedCrossRefGoogle Scholar
  19. 19.
    Roche, W. R. (1985). Mast cells and tumours. The specific enhancement of tumour proliferation in vitro. Am. J. Pathol., 119, 57PubMedGoogle Scholar
  20. 20.
    Roche, W. R. (1985). Mast cells and tumour angiogenesis: the tumour-mediated release of an endothelial growth factor from mast cells. Int. J. Cancer, 36, 721PubMedCrossRefGoogle Scholar
  21. 21.
    Knupp, C., Pekala, P. H. and Cornelius, P. (1988). Extensive bone marrow necrosis in patients with cancer and tumor necrosis factor activity in plasma. Am. J. Haematol., 29, 215CrossRefGoogle Scholar
  22. 22.
    Burtis, W. J., Wu, R. L, Insogna, K. L. and Stewart, A. F. (1988). Humoral hypercalcemia of malignancy. Ann. Intern. Med., 108, 454PubMedGoogle Scholar
  23. 23.
    Broadus, A. E., Mangin, M., Ikeda, K., Insogna, K. L, Weir, E. C., Burtis, W. J. and Stewart, A. F. (1988). Humoral hypercalcemia of cancer. Identification of a novel parathyroid hormone-like peptide. N. Engl. J. Med., 318, 556Google Scholar
  24. 24.
    Elomas, I., Blomqvist, C., Porkka, L, Lamberg-Allandt, C. and Borgstrom, G. H. (1987). Treatment of skeletal disease in breast cancer: a controlled clodronate trial. Bone, 8, (Suppl. 1), S53Google Scholar
  25. 25.
    Canfield, R. E., Sims, E. S. and Jacobs, T. P. (1987). Dichloromethy-lene disphosphonate action in hematological and other malignancies. Bone, 8, (Suppl. 1), S57PubMedGoogle Scholar
  26. 26.
    Morton, A. R., Cantrill, J. A., Pillai, G. V., McMahon, A., Anderson, D. C. and Howell, A. (1988). Sclerosis of lytic bone metastases after disodium aminohydroxypropylidene bisphosphonate (ADP) in patients with breast carcinoma. Br. Med. J., 297, 772CrossRefGoogle Scholar
  27. 27.
    Editorial, anonymous (1985). Dilemmas in the management of prostatic carcinoma. Lancet, 2, 1219Google Scholar
  28. 28.
    Patenson, A. H. G. (1987). Bone metastases in breast cancer, prostate cancer and myeloma. Bone, 8 (Suppl. 1), S17Google Scholar
  29. 29.
    Soloway, M. S., Hardeman, S. W., Hickey, D., Raymond, J., Todd, B., Soloway, S. and Moinuddin, M. (1988). Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan. Cancer, 61, 195PubMedCrossRefGoogle Scholar
  30. 30.
    Berger, U., Bettelheim, R., Mansi, J. L, Easton, D., Coombes, R. C. and Munro Neville, A. (1988). The relationship between micromet-astases in the bone marrow, histopathologic features of the primary tumor in breast cancer and prognosis. Am. J. Clin. Pathol., 90, 1PubMedGoogle Scholar
  31. 31.
    Mansi, J. L, Berger, U., Easton, D., McDonnell, T., Redding, W. H., Gazet, J.-C, McKinna, A., Powles, T. J. and Coombes, F. C. (1987). Micrometastases in bone marrow in patients with primary breast cancer: evaluation as an early prediction of bone metastases. Br. Med. J., 295, 1093CrossRefGoogle Scholar
  32. 32.
    Zajicek, G. (1987). Long survival with micrometastasis. At least 9% of breast cancer patients carry metastases for more than 10 years. Cancer J., 1, 381Google Scholar
  33. 33.
    Ceci, G., Franciosi, V., Nizzoli, R., De Lisi, V., Lottici, R., Boni, C., Di Blasio, B., Passalacqua, R., Guazzi, A. and Cocconi, G. (1988). The value of bone marrow biopsy in breast cancer at time of diagnosis. A prospective study. Cancer, 61, 96PubMedCrossRefGoogle Scholar
  34. 34.
    Untch, M., Harbeck, N. and Eiermann, W. (1988). Micrometastases in bone marrow in patients with breast cancer. Br Med. J., 296, 290CrossRefGoogle Scholar
  35. 35.
    Kamby, C., Guldhamer, B., Vejborg, I., Rossing, N., Dirksen, H., Daugaard, S. and Mouridsen, H. T. (1987). The presence of tumor cells in bone marrow at the time of first recurrence of breast cancer. Cancer, 60, 1306PubMedCrossRefGoogle Scholar
  36. 36.
    Manegold, C., Krempien, B., Kaufmann, M., Schwechheimer, K. and Schettler, G. (1988). The value of bone marrow examination for tumor staging in breast cancer. J. Cancer Res. Clin. Oncol., 114, 425PubMedCrossRefGoogle Scholar
  37. 37.
    Porro, G., Menard, S., Tagliabue, E., Orefice, S., Salvadori, B., Squicciarini, P., Amdreola, S., Rilke, F. and Colnaghi, M. I. (1988). Monoclonal antibody detection of carcinoma cells in bone marrow biopsy specimens from breast cancer patients. Cancer, 61, 2407PubMedCrossRefGoogle Scholar
  38. 38.
    Reske, S. N., Gloekner, W., Schwarz, A., Karstens, J. H., Steinstrasser, A. and Ammon, J, (1989). Radioimmunoimaging for diagnosis of bone marrow involvement in breast cancer and malignant lymphoma. Lancet, 1 (8633), 299PubMedCrossRefGoogle Scholar
  39. 39.
    Coleman, R. E. and Rubens, R. D. (1985). Bone metastases and breast cancer. Cancer Treat. Rev., 12, 251PubMedCrossRefGoogle Scholar
  40. 40.
    Clamon, G. H., Edwards, W. R., Hamous, J. E. and Scupham, R. K. (1984). Patterns of bone marrow involvement with small cell lung cancer. Cancer, 54, 100PubMedCrossRefGoogle Scholar
  41. 41.
    Stahel, R. A., Mabry, M., Skarm, A. T., Speak, J. and Bernai, S. D. (1985). Detection of bone marrow metastasis in small-cell lung cancer by monoclonal antibody. J. Clin. Oncol., 3, 455PubMedGoogle Scholar
  42. 42.
    Battifora, H. and Silva, E. G. (1986). The use of antikeratin antibodies in the immunohistochemical distinction between neuroendocrine (Merkel Cell) carcinoma of the skin, lymphoma, and oat cell carcinoma. Cancer 58, 1040PubMedCrossRefGoogle Scholar
  43. 43.
    Ariza, A., Bitterman, P. and Nash, I. (1986). Diagnosis of intestinal carcinoid tumor by bone marrow biopsy. Connecticut Med., 50, 307Google Scholar
  44. 44.
    Jayabose, S., Igbal, K., Newman, L., San Filippo, J. A., Davidian, M. M., Noto, R. and Sagel, I. (1988). Hypercalcemia in childhood renal tumors. Cancer, 61, 788PubMedCrossRefGoogle Scholar
  45. 45.
    Bostrom, B., Nesbit, M. E. Jr and Brunning, R. D. (1985). The value of bone marrow trephine biopsy in the diagnosis of metastatic neuroblastoma. Am. J. Pediatr Hematol. Oncol, 7, 303PubMedCrossRefGoogle Scholar
  46. 46.
    Kushner, B. H., Helson, L, Lane, J. M. and Hadju, S. L (1986). Metastatic neuroblastoma after 52 years of apparent dormancy. N. Engl. J. Med., 315, 196PubMedCrossRefGoogle Scholar
  47. 47.
    Favrot, M. C., Frappaz, D., Maritaz, O., Philip, I., Fontaniere, B., Gentihomme, O., Bailly, C., Zucker, J. M., Gentet, J. C., Kemshead, J. et al. (1986). Histological, cytological and immunological analyses are complementary for the detection of neuroblastoma cells in bone marrow. Br. J. Cancer, 54, 637PubMedCrossRefGoogle Scholar
  48. 48.
    Reid, M. M. and Hamilton, P.J. (1988). Histology of neuroblastoma involving bone marrow: the problem of detecting residual tumour after initiation of chemotherapy. Br. J. Haematol., 69, 487PubMedCrossRefGoogle Scholar
  49. 49.
    Javier de la Serna, F., Matrinez, M. A., Valdes, M. D., Hornedo, J., Mestre, M. J. and Morales, J. M. (1988). Rhabdomyosarcoma presenting with diffuse bone marrow involvement, hypercalcemia and renal failure. Med. Pediat. Oncol., 16, 123CrossRefGoogle Scholar
  50. 50.
    Ruymann, F. B., Newton, W. A., Ragab, A. H., Donaldson, M. H. and Foulkes, M. (1984). Bone marrow metastases at diagnosis in children and adolescents with rhabdomyosarcoma. A report from the Intergroup Rhabdomyocarcoma Study. Cancer, 53, 368PubMedCrossRefGoogle Scholar
  51. 51.
    Conran, R. M., Granger, E. and Reddy, V. B. (1986). Koposi’s sarcoma of the bone marrow. Arch. Pathol. Lab. Med., 110, 1083PubMedGoogle Scholar
  52. 52.
    Little, B. J., Spivak, J. L, Quinn, T. C. and Mann, R. B. (1986). Kaposi’s sarcoma with bone marrow involvement: occurrence in a patient with acquired immunodeficiency syndrome. Am. J. Med. Sci., 292, 44PubMedCrossRefGoogle Scholar
  53. 53.
    Gatten, K. C., Heryet, A., Alcok, C. and Mason, D. Y. (1985). Clinical importance of analysing malignant tumours of uncertain origin with immunohistological technique. Lancet, 1(8441), 1302Google Scholar
  54. 54.
    Simon, M. A. and Bartucci, E. J. (1986). The search for the primary tumor in patients with skeletal metastases of unknown origin. Cancer, 58, 1088PubMedCrossRefGoogle Scholar
  55. 55.
    Ringenberg, Q. S., Doll, D. C., Yarbro, J. W. and Perry, M. C. (1986). Tumors of unknown origin in the bone marrow. Arch. Intern. Med., 146, 2027PubMedCrossRefGoogle Scholar
  56. 56.
    Micheau, C., Boussen, H., Klinjanienko, J., Cvikovic, E., Stosic, S., Schwaab, G., Eschwege, F. and Armand, J. P. (1987). Bone marrow biopsies in patients with undifferentiated carcinoma of the nasopharyngeal type. Cancer, 60, 2459PubMedCrossRefGoogle Scholar
  57. 57.
    LoRusso, P. M., Tapazoglou, E., Zarbo, R. J., Cullis, P. A., Austin, D. and Al-Sarraf, M. (1988). Intracranial astrocytoma with diffuse bone marrow metastasis: a case report and review of the literature. J. Neurooncol., 6, 53PubMedCrossRefGoogle Scholar
  58. 58.
    Rosenberg, A. E., Garber, J. E., Bennett, W., Bhan, A. K., Antman, K. H. and Mark, E. J. (1988). Epithelioid sarcoma with diffuse bone marrow metastases and associated leukemoid reaction. A case report and brief literature review. Am. J. Clin. Pathol., 90, 723PubMedGoogle Scholar

Copyright information

© B. Frisch and R. Bartl 1990

Authors and Affiliations

  • B. Frisch
    • 1
  • R. Bartl
    • 2
  1. 1.Institute of Haematology, Ichilov Hospital and Sackler Faculty of MedicineTel-Aviv UniversityIsrael
  2. 2.Bone Marrow Diagnosis Dept. of Internal Medicine “Innenstadt”University of MunichGermany

Personalised recommendations